You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海凱寶(300039.SZ):目前公司暫無治療猴痘的相關產品
格隆匯 09-23 15:29

格隆匯9月23日丨上海凱寶(300039.SZ)在投資者互動平台表示,目前公司暫無治療猴痘的相關產品。公司主營產品痰熱清注射液在“人禽流感”、“甲型H1N1流感”、“甲型H7N9流感”、“手足口病”、“登革熱”、“埃博拉”、“中東呼吸綜合徵”、“新冠肺炎”等防控中均被國家衞健委和中醫藥管理局列為臨牀指南或診療方案用藥。2024年7月,國家衞生健康委辦公廳下發《關於印發麻疹等傳染病診療方案(2024年版)的通知》,公佈了麻疹、登革熱、人感染禽流感三類季節傳染類疾病診療方案,痰熱清注射液均被列為上述診療方案用藥。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account